Exercise Regimen Can Improve Fatigue in Patients With Advanced Prostate Cancer
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 18, 2025 -- For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a significant improvement in fatigue and peak exercise capacity, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 13 to 15 in San Francisco.
Benjamin Maughan, M.D., Pharm.D., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues conducted a prospective trial involving patients with aPC treated with an androgen deprivation therapy-based regimen and participating in a 12-week exercise program. Eligible participants had at least 4/10 tiredness, self-reported sedentary lifestyle (<90 minutes/week of exercise), no evidence of disease progression, and no chemotherapy within three months. Peak aerobic capacity, muscular strength, and endurance testing were assessed before and after 12 weeks of structured, guided exercise.
A total of 119 participants with aPC were enrolled (92 percent with metastatic disease); nine participants withdrew and 10 were lost to follow-up. The primary end point was evaluable in 72 patients. The researchers found that from baseline to 12 weeks, there was a clinically significant 5.1-point reduction in fatigue. In 76 patients who completed both aerobic fitness assessments, there was a 3.1 mL/kg/min improvement in relative peak aerobic capacity (mean of 27.5 at baseline to 30.6 at 12 weeks).
"These findings support routinely recommending exercise for and examining symptom management in patients with metastatic cancer to improve quality of life," the authors write.
Several authors disclosed ties to the pharmaceutical and biotechnology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Risk of Long COVID Greater for Individuals With Social Risk Factors
THURSDAY, July 31, 2025 -- Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for...
Racial Differences Seen in Prostate Cancer Care Quality
WEDNESDAY, July 30, 2025 -- Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a...
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 -- Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.